Skip to main content
. Author manuscript; available in PMC: 2024 Nov 7.
Published in final edited form as: Breast Cancer Res Treat. 2023 Oct 31;203(3):553–564. doi: 10.1007/s10549-023-07148-y

Table 1.

Demographic and clinical characteristics by time-to-surgery category, racial/ethnic background, and surgery type (N = 2069)

Characteristic Total sample, n (%) Time from cancer diagnosis to initial surgical therapy Racial/ethnic background Surgical treatment type
Less than 1 month, n = 1130 (55%) Between 1 and 2 months, n = 604 (29%) More than 2 months, n = 335 (16%) P-value Non-hispanic White (n = 1750) Non-hispanic Black (n = 158) Hispanic (n = 161) P-value Mastectomy (n = 856) 41.4% BCS (n = 1213) 58.6% P-value
Age at survey
Median 75.0 74.7 75.6 74.6 0.592 75.2 73.0 73.8 <0.001 75.9 74.3 0.004
Mean (SD) 75.6 (6.4) 75.5 (6.5) 75.8 (6.0) 75.7 (6.6) 75.8 (6.4) 73.9 (6.0) 74.9 (5.9) 76.1 (6.4) 75.3 (6.3)
66–69 471 (22.8) 276 (24.4) 118 (19.5) 77 (23.0) 0.172 379 (21.7) 49 (31.0) 43 (26.7) 0.027 180 (21.0) 291 (24.0) 0.019
70–74 577 (27.9) 311 (27.5) 169 (28.0) 97 (29.0) 483 (27.6) 49 (31.0) 45 (27.9) 218 (25.5) 359 (29.6)
75–79 501 (24.2) 256 (22.7) 171 (28.3) 74 (22.1) 424 (24.2) 36 (22.8) 41 (25.5) 231 (27.0) 270 (22.3)
80–84 338 (16.3) 187 (16.6) 98 (16.2) 53 (15.8) 303 (17.3) < 11% < 12% 142 (16.6) 196 (16.2)
85 + 182 (8.8) 100 (8.8) 48 (8.0) 34 (10.1) 161 (9.2) < 7% < 7% 85 (9.9) 97 (8.0)
Race/ethnicity 0.037 0.797
 Non-hispanic White 1,750 (84.6) 973 (86.1) 505 (83.6) 272 (81.2) 719 (84.0) 1,031 (85.0)
 Non-hispanic Black 158 (7.6) 83 (7.4) 51 (8.4) 24 (7.2) 69 (8.1) 89 (7.3)
 Hispanic 161 (7.8) 74 (6.5) 48 (8.0) 39 (11.6) 68 (7.9) 93 (7.7)
Marital status 0.971 0.006 0.714
 Not married 1,120 (54.1) 610 (54.0) 325 (53.8) 185 (55.2) 927 (53.0) 108 (68.3) 85 (52.8) 462 (54.0) 658 (54.3)
 Married 871 (42.1) 475 (42.0) <43% <42% 755 (43.1) < 29% < 42% 365 (42.6) 506 (41.7)
 Unknown 78 (3.8) 45 (4.0) <4% <4% 68 (3.9) < 7% < 7% 29 (3.4) 49 (4.0)
Education level 0.165 <0.001 0.024
 High school or less 1,165 (56.3) 654 (57.9) 321 (53.2) 190 (56.7) 945 (54.0) 107 (67.7) 113 (70.2) 507 (59.2) 658 (54.3)
 Some college + 904 (43.7) 476 (42.1) 283 (46.8) 145 (43.3) 805 (46.0) 51 (32.3) 48 (29.8) 349 (40.8) 555 (45.7)
Self-reported comorbidities 0.194 0.014 0.149
 0 1,624 (78.5) 899 (79.6) 476 (78.8) 249 (74.3) 1397 (79.8) 114 (72.2) 113 (70.2) 662 (77.3) 962 (79.3)
 1 318 (15.4) 166 (14.7) 95 (15.7) 57 (17.0) 254 (14.5) 31 (19.6) 33 (20.5) 131 (15.3) 187 (15.4)
 2 + 127 (6.1) 65 (5.6) 33 (5.5) 29 (8.7) 99 (5.7) 13 (8.2) 15 (9.3) 63 (7.4) 64 (5.3)
Tumor stage 0.906 0.178 <0.001
 I 1212 (58.6) 662 (58.6) 357 (59.1) 193 (57.6) 1,040 (59.4) 84 (53.2) 88 (54.6) 352 (41.1) 860 (70.9)
 II–III 857 (41.4) 468 (41.4) 247 (40.9) 142 (42.4) 710 (40.6) 74 (46.8) 73 (45.4) 504 (58.9) 353 (29.1)
Type of surgery 0.438 0.797
 Breast conserving 1213 (58.6) 655 (57.9) 351 (58.2) 207 (61.8) 1,031 (58.9) 89 (56.3) 93 (57.8)
 Mastectomy 856 (41.4) 475 (42.1) 253 (41.8) 128 (38.2) 719 (41.1) 69 (43.7) 68 (42.2)
Medicare plan <0.001 <0.001 0.783
 MA PDP 430 (20.8) 193 (17.1) 148 (24.5) 89 (26.6) 327 (18.7) 57 (36.1) 46 (28.6) 182 (21.3) 248 (20.5)
 MA only 865 (41.8) 504 (44.6) 235 (38.9) 126 (37.6) 737 (42.1) 53 (33.5) 75 (46.6) 354 (41.4) 511 (42.1)
 FFS PDP 314 (15.2) 162 (14.3) 96 (15.9) 56 (16.7) 275 (15.7) 22 (13.9) 17 (10.6) 136 (15.9) 178 (14.7)
 FFS only 460 (22.2) 271 (24.0) 125 (20.7) 64 (19.1) 411 (23.5) 26 (16.5) 23 (14.2) 184 (21.5) 276 (22.7)
Geographic region <0.001 <0.001 <0.001
 West 1159 (56.0) 588 (52.0) 356 (59.0) 215 (64.2) 992 (56.7) 40 (25.3) 127 (78.9) 482 (56.3) 677 (55.8)
 Midwest 181 (8.7) 96 (8.5) 60 (9.9) 25 (7.5) 158 (9.0) <11% <7% 81 (9.5) 100 (8.2)
 North East 322 (15.6) 191 (16.9) 79 (13.1) 52 (15.5) 278 (15.9) 26 (16.5) 18 (11.2) 98 (11.4) 224 (18.5)
 South 407 (19.7) 255 (22.6) 109 (18.5) 43 (12.8) 322 (18.4) <48% <7% 195 (22.8) 212 (17.5)
Survey administration mode 0.639 <0.001 0.388
 Mail 357 (17.3) 197 (17.4) 108 (17.9) 52 (15.5) 277 (15.8) 37 (23.4) 43 (26.7) 155 (18.1) 202 (16.7)
 Phone 1712 (82.7) 933 (82.6) 496 (82.1) 283 (84.5) 1,473 (84.2) 121 (76.6) 118 (73.3) 701 (81.9) 1,011 (83.3)
Survey year <0.001 <0.001 0.099
 1997–2000 360 (17.4) 234 (20.7) 90 (14.9) 36 (10.8) 308 (17.6) 23 (14.6) 29 (18.0) 167 (19.5) 193 (15.9)
 2001–2005 787 (38.0) 450 (39.8) 217 (35.9) 120 (35.8) 689 (39.4) 43 (27.2) 55 (34.2) 314 (36.7) 473 (39.0)
 2007–2011 922 (44.6) 446 (39.5) 297 (49.2) 179 (53.4) 753 (44.0) 92 (58.2) 77 (47.8) 375 (43.8) 547 (45.1)
Time from survey to cancer diagnosis 0.619 0.581 0.619
 ≤ 6 months 547 (26.4) 291 (25.8) 165 (27.3) 91 (27.2) 473 (27.0) 35 (22.2) 39 (24.2) 221 (25.8) 326 (26.9)
 6 to < 12 mo 550 (26.6) 299 (26.5) 164 (27.2) 87 (25.9) 454 (26.0) 46 (29.1) 50 (31.1) 230 (26.9) 320 (26.4)
 12 to< 18 mo 476 (23.0) 254 (22.5) 135 (22.4) 87 (25.9) 408 (23.3) 34 (21.5) 34 (21.1) 188 (22.0) 288 (23.7)
 18 to 24 mo 496 (24.0) 286 (25.3) 140 (23.1) 70 (21.0) 415 (23.7) 43 (27.2) 38 (23.6) 217 (25.3) 279 (23.0)
Doctor communication (n = 1578) 88.5 (16.8) 88.2 (16.6) 89.3 (16.4) 87.8 (18.3) 0.421 88.3 (17.0) 88.4 (15.6) 90.2 (16.4) 0.515 89.1 (15.9) 88.0 (17.4) 0.186
Getting care quickly (n = 1546) 83.9 (23.2) 84.3 (22.6) 84.2 (23.1) 82.1 (25.3) 0.383 84.1 (22.7) 80.0 (28.2) 85.1 (24.3) 0.182 84.9 (22.4) 83.3 (23.7) 0.194
Getting needed care (n = 1701) 88.3 (21.2) 88.5 (21.5) 88.7 (20.5) 86.7 (21.3) 0.422 89.0 (20.4) 83.5 (26.2) 84.4 (24.2) 0.002 89.4 (20.4) 87.5 (21.7) 0.072
Getting needed Rx (n = 1763) 91.0 (20.5) 90.8 (21.5) 91.2 (20.0) 91.6 (18.0) 0.808 91.9 (19.4) 83.9 (22.8) 89.0 (22.8) <0.001 90.2 (22.1) 91.6 (19.3) 0.134

P-value represents a two-sided t-test, chi-square test, or one-way ANOVA

mo months

*

CAHPS means are unadjusted